IFIDANCITINIB

UNII:	R105E71J13
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₀H₁₈FN₅O₃
Preferred Substance Name:	IFIDANCITINIB
InChIKey:	OYFMQDVLFYKOPZ-UHFFFAOYSA-N
GSRS Full Record:	R105E71J13 i

1236667-40-5
2(3H)-BENZOXAZOLONE, 5-((2-((4-FLUORO-3-METHOXY-5-METHYLPHENYL)AMINO)-5-METHYL-4-PYRIMIDINYL)AMINO)-
5-((2-((4-FLUORO-3-METHOXY-5-METHYLPHENYL)AMINO)-5-METHYL-4-PYRIMIDINYL)AMINO)-2(3H)-BENZOXAZOLONE
5-((2-(4-FLUORO-3-METHOXY-5-METHYLPHENYLAMINO)-5-METHYLPYRIMIDIN-4-YL)AMINO)BENZO(D)OXAZOL-2(3H)-ONE
5-[[2-(4-fluoro-3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-3H-1,3-benzoxazol-2-one
5-[[2-(4-fluoro-3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-3H-1,3-benzoxazol-2-one
A-301
ATI-50002
ATI-502
ATI50002
Ifidancitinib
Ifidancitinib [WHO-DD]
ifidancitinib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

IFIDANCITINIB

Synonyms and Mappings

Resources